Last reviewed · How we verify
NCT06557434
AV-23-001 AVAVA MIRIA Pilot Study
NA trial testing MIRIA in Wrinkle in 200 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2026
Quick facts
| Lead sponsor | AVAVA, Inc. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 6 November 2023 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- MIRIA
Conditions studied
- Wrinkle — all drugs for Wrinkle →
- Acne Scars - Mixed Atrophic and Hypertrophic — all drugs for Acne Scars - Mixed Atrophic and Hypertrophic →
- Pigmented Lesions — all drugs for Pigmented Lesions →
- Skin Laxity — all drugs for Skin Laxity →
Sponsor
AVAVA, Inc.
Who can join
18 and older, any sex, with Wrinkle or Acne Scars - Mixed Atrophic and Hypertrophic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural irregularities, or scars). The study is also intended to assist in determination of the optimal laser configuration and treatment parameters that most consistently yield results.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06557434
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wrinkle
Currently open trials in the same condition.
- NCT06868615 — AVAVA MIRIA General Use · NA · recruiting
- NCT06571721 — The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles · NA · recruiting
- NCT06385171 — Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation · recruiting
- NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting
- NCT06074276 — The Effects of Almond on Facial Skin Collagen and Wrinkles · NA · recruiting
Other AVAVA, Inc. trials
Trials by the same sponsor.
- NCT06868615 — AVAVA MIRIA General Use · NA · recruiting
- NCT05597267 — The MIRIA Acne Scar Study · NA · active not recruiting
- NCT04925921 — AVAVA SR-1 Wrinkles and BPL Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06557434 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AVAVA, Inc.
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06557434.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing